|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,730.00 KRW | +2.38% |
|
+2.49% | -30.65% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.38% | +2.49% | -48.70% | - | 73.35M | ||
| -0.17% | -1.91% | +86.29% | +461.34% | 39.72B | ||
| +1.93% | -0.41% | +12.41% | +30.06% | 22.3B | ||
| +1.21% | -0.50% | -20.28% | -39.12% | 7.43B | ||
| +3.59% | -3.47% | +11.16% | +95.79% | 4.83B | ||
| +0.55% | +4.79% | +16.51% | +47.05% | 2.99B | ||
| -3.38% | -7.77% | -20.47% | +758.99% | 1.96B | ||
| +1.55% | -0.27% | +112.59% | -14.54% | 1.89B | ||
| -0.50% | +21.52% | -3.79% | -63.57% | 1.92B | ||
| +3.17% | +13.20% | +39.25% | -15.68% | 1.85B | ||
| Average | +1.04% | +1.38% | +18.50% | +140.04% | 8.5B | |
| Weighted average by Cap. | +0.78% | +0.04% | +45.80% | +242.89% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















